Company News

Three Abstracts Featuring MyoStrain Presented at the American Heart Association 2018 Scientific Sessions

November 13, 2018
Company News

CHICAGO, I.L., November 13, 2018 – A series of three abstracts utilizing MyoStrain®, Myocardial Solutions’ patented technology, were accepted and presented at American Heart Association (AHA) 2018 Scientific Sessions on November 10-12, 2018. The abstracts were based on studies conducted at Sharon Regional Medical Center in Sharon, PA. Dr. Ronald Mikolich conducted and presented the studies.

Links to the abstracts are provided below:

Title: Detection of Sub-clinical Left Ventricular Dysfunction in Obese Patients

Citation: Kulifay S, et al. Detection of Sub-clinical Left Ventricular Dysfunction in Obese Patients. AHA Scientific Sessions 2018

Title: Evidence of Sub-clinical Left Ventricular Dysfunction in Pericarditis

Citation: Long J, et al.  Evidence of Sub-clinical Left Ventricular Dysfunction in Pericarditis. AHA Scientific Sessions 2018

Title: Effect of Regadenoson Vasodilator Stress on Left Ventricular Strain

Citation: Hoff E, et al.  Effect of Regadenoson Vasodilator Stress on Left Ventricular Strain. AHA Scientific Sessions 2018

Media Contact

PR@myocardialsolutions.com
919.677.8100

About Myocardial Solutions, Inc.

Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.

To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.  

808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100

© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM 
Score are among the trademarks of Myocardial Solutions.